Evinance, founded in 2012, aims to revolutionize healthcare decision-making by promoting collaboration between doctors and patients. Their patented technology seamlessly integrates evidence-based guidelines, including those from the National Comprehensive Cancer Network® (NCCN®), into clinical workflows. The Evinance Decision Support Platform facilitates shared decision-making through virtual patient pathways, improving patient communication. Based in Montreal, Quebec, the company's platform is designed to interface with any EHR, medical specialty, and language. The last investment, a Non-Equity Assistance investment, was received on 29 September 2013 from VentureOut. Evinance operates at the intersection of Digital Health, Health Care, and Health and Wellness industries, presenting a promising opportunity in the evolving healthcare technology landscape.
No recent news or press coverage available for Evinance.